Market Pulse Archives

April 13, 2021, 2:10 p.m. EDT

CDC committee to hold emergency meeting for J&J's COVID-19 shot on Wednesday afternoon

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

JNJ

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is scheduled to hold an emergency meeting on Wednesday, starting at 1:30 p.m. Eastern Time, in response to a federal recommendation made Tuesday to temporarily halt immunizations using Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ -0.22% COVID-19 vaccine. The recommendation was made after six people who received the J&J shot were diagnosed with severe blood clots in combination with low levels of blood platelets. About 6.8 million people in the U.S. in total have been administered the J&J vaccine. The meeting, which will be publicly webcast, is expected to conclude with a vote about whether the vaccine should continue to be used, how it should be used going forward, or how people who develop blood clots as a result of the vaccine should be treated. The ACIP in February recommended the vaccine after the Food and Drug Administration granted the emergency authorization.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 166.70
-0.37 -0.22%
Volume: 47,433
May 6, 2021 9:39a
P/E Ratio
29.51
Dividend Yield
2.54%
Market Cap
$439.96 billion
Rev. per Employee
$613,918
loading...

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.